Late rectal toxicity after conformal radiotherapy of prostate cancer (I):: Multivariate analysis and dose-response

被引:266
作者
Skwarchuk, MW
Jackson, A
Zelefsky, MJ
Venkatraman, ES
Cowen, DM
Levegrün, S
Burman, CM
Fuks, Z
Leibel, SA
Ling, CC
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
[4] Paoli Calmettes Canc Ctr, Dept Radiat Oncol, Marseille, France
[5] Deutsch Krebsforschungszentrum, Dept Med Phys, Heidelberg, Germany
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 47卷 / 01期
关键词
rectum; prostate; toxicity; late; radiation;
D O I
10.1016/S0360-3016(99)00560-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this paper is to use the outcome of a dose escalation protocol for three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer to study the dose-response for late rectal toxicity and to identify anatomic, dosimetric, and clinical factors that correlate with late rectal bleeding in multivariate analysis. Methods and Materials: Seven hundred forty-three patients with T1c-T3 prostate cancer were treated with 3D-CRT with prescribed doses of 64.8 to 81.0 Gy. The 5-year actuarial rate of late rectal toxicity was assessed using Kaplan-Meier statistics. A retrospective dosimetric analysis was performed for patients treated to 70.2 Gy (52 patients) or 75.6 Gy (119 patients) who either exhibited late rectal bleeding (RTOG Grade 2/3) within 30 months after treatment (i.e,, 70.2 Gy-13 patients, 75.6 Gy-36 patients) or were nonbleeding for at least 30 months (i.e,, 70.2 Gy-39 patients, 75.6 Gy-83 patients). Univariate and multivariate logistic regression was performed to correlate late rectal bleeding with several anatomic, dosimetric, and clinical variables. Results: A dose response for greater than or equal to Grade 2 late rectal toxicity was observed. By multivariate analysis, the following factors were significantly correlated with greater than or equal to Grade 2 late rectal bleeding for patients prescribed 70.2 Gy: 1) enclosure of the outer rectal contour by the 50% isodose on the isocenter slice (i.e., Iso50) (p < 0.02), and 2) smaller anatomically defined rectal wall volume (p < 0.05), After 75.6 Gy, the following factors were significant: 1) smaller anatomically defined rectal wall volume (p < 0.01), 2) higher rectal D-max (p < 0.01), 3) enclosure of rectal contour by Iso50 (p < 0.01), 4) patient age (p = 0.02), and 5) history of diabetes mellitus (p = 0.04). In addition to these five factors, acute rectal toxicity was also significantly correlated (p = 0.05) with late rectal bleeding when patients from both dose groups were combined in multivariate analysis. Conclusion: A multivariate logistic regression model is presented which describes the probability of developing late rectal bleeding after conformal irradiation of prostate cancer. Late rectal bleeding correlated with factors which may indicate that a greater fractional volume of rectal wall was exposed to high dose, such as smaller rectal wall volume, inclusion of the rectum within the 50% isodose on the isocenter slice, and higher rectal D-max. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 36 条
[1]   Prostate target volume variations during a course of radiotherapy [J].
Antolak, JA ;
Rosen, II ;
Childress, CH ;
Zagars, GK ;
Pollack, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (03) :661-672
[2]   MEASUREMENT OF PROSTATE MOVEMENT OVER THE COURSE OF ROUTINE RADIOTHERAPY USING IMPLANTED MARKERS [J].
BALTER, JM ;
SANDLER, HM ;
LAM, K ;
BREE, RL ;
LICHTER, AS ;
TENHAKEN, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (01) :113-118
[3]   Analysis of prostate and seminal vesicle motion: Implications for treatment planning [J].
Beard, CJ ;
Kijewski, P ;
Bussiere, M ;
Gelman, R ;
Gladstone, D ;
Shaffer, K ;
Plunkett, M ;
Costello, P ;
Coleman, CN .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02) :451-458
[4]   LATE RECTAL BLEEDING FOLLOWING COMBINED X-RAY AND PROTON HIGH-DOSE IRRADIATION FOR PATIENTS WITH STAGES T3-T4 PROSTATE CARCINOMA [J].
BENK, VA ;
ADAMS, JA ;
SHIPLEY, WU ;
URIE, MM ;
MCMANUS, PL ;
EFIRD, JT ;
WILLETT, CG ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (03) :551-557
[5]   Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms [J].
Boersma, LJ ;
van den Brink, M ;
Bruce, AM ;
Shouman, T ;
Gras, L ;
te Velde, A ;
Lebesque, JV .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01) :83-92
[6]   Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate [J].
Burman, C ;
Chui, CS ;
Kutcher, G ;
Leibel, S ;
Zelefsky, M ;
LoSasso, T ;
Spirou, S ;
Wu, QW ;
Yang, J ;
Stein, J ;
Mohan, R ;
Fuks, Z ;
Ling, CC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :863-873
[7]   FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[8]   Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy [J].
Dale, E ;
Olsen, DR ;
Fosså, SD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02) :385-391
[9]   COMPLICATION PROBABILITY FACTOR - METHOD FOR SELECTION OF RADIATION TREATMENT PLANS [J].
DRITSCHILO, A ;
CHAFFEY, JT ;
BLOOMER, WD ;
MARCK, A .
BRITISH JOURNAL OF RADIOLOGY, 1978, 51 (605) :370-374
[10]   Results of 3D conformal radiotherapy in the treatment of localized prostate cancer [J].
FukunagaJohnson, N ;
Sandler, HM ;
McLaughlin, PW ;
Strawderman, MS ;
Grijalva, KH ;
Kish, KE ;
Lichter, AS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (02) :311-317